Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Artificial intelligence applied to omics data in liver diseases: Enhancing clinical predictions. | Front Artif Intell | 2022 | 36458100 | PubTator, text mining | PubMed |
| Mechanisms in AIT: Insights 2021. | Allergol Select | 2022 | 36457721 | PubTator, text mining | PubMed |
| Benchmarking challenging small variants with linked and long reads. | Cell Genom | 2022 | 36452119 | PubTator, text mining | PubMed |
| Mechanisms and biomarkers of successful allergen-specific immunotherapy. | Asia Pac Allergy | 2022 | 36452016 | PubTator, text mining | PubMed |
| Self-assembly of X-shaped antibody to combine the activity of IgG and IgA for enhanced tumor killing. | Theranostics | 2022 | 36451853 | PubTator, text mining | PubMed |
| Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer. | Front Immunol | 2022 | 36439090 | PubTator, text mining | PubMed |
| A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma. | Front Genet | 2022 | 36437960 | PubTator, text mining | PubMed |
| Human Lung Mast Cells: Therapeutic Implications in Asthma. | Int J Mol Sci | 2022 | 36430941 | PubTator, text mining | PubMed |
| Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy. | Int J Mol Sci | 2022 | 36430817 | PubTator, text mining | PubMed |
| Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma. | Cells | 2022 | 36429020 | PubTator, text mining | PubMed |
| Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy. | Sci Adv | 2022 | 36427310 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals a novel inhibitory effect of ApoA4 on NAFL mediated by liver-specific subsets of myeloid cells. | Front Immunol | 2022 | 36426356 | PubTator, text mining | PubMed |
| Development of therapeutic antibodies for the treatment of diseases. | Mol Biomed | 2022 | 36418786 | PubTator, text mining | PubMed |
| Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma. | PLoS One | 2022 | 36417422 | PubTator, text mining | PubMed |
| Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A. | Langmuir | 2022 | 36416530 | PubTator, text mining | PubMed |
| The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity. | Front Immunol | 2022 | 36389824 | PubTator, text mining | PubMed |
| The clinical significance of allergen-specific IgG4 in allergic diseases. | Front Immunol | 2022 | 36389804 | PubTator, text mining | PubMed |
| Periodontal disease in pregnancy and adverse pregnancy outcomes: Progress in related mechanisms and management strategies. | Front Med (Lausanne) | 2022 | 36388896 | PubTator, text mining | PubMed |
| The why and how of adaptive immune responses in ischemic cardiovascular disease. | Nat Cardiovasc Res | 2022 | 36382200 | PubTator, text mining | PubMed |
| Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. | EBioMedicine | 2022 | 36371989 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=35